Sun Pharmaceutical Industries Stock Forecast for 2023 - 2025 - 2030

Updated on 02/28/2024

Stock Rating
8
Price Target
Rp1.57k
Consensus
Outperform
Downside
-0.74%
Analysts
24
Stock Rating
8
Downside
-0.74%
Analysts
24
Price Target
Rp1.57k

Sun Pharmaceutical Industries Stock Forecast and Price Target

The average price target for Sun Pharmaceutical Industries's stock of Rp1571.00 recently provided by Twenty four leading analysts would represent a -0.74% downside from its last closing price if reached. This potential increase is based on a high estimate of Rp1680.00 and a low estimate of Rp1200.00. If you're thinking of investing in SUNPHARMA stock, it might be good to look at its rivals too.

Rp1.57k

-0.74% Downside

Outperform
Outperform

Sun Pharmaceutical Industries Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Sun Pharmaceutical Industries's Price has decreased from Rp451.69 to Rp0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach Rp1059.29 – an increase of 100.00%. For the next seven years, the forecast is forFair Value to grow by 100.00%.

2024 Fair Value Forecast
Rp1.06k
2025 Fair Value Forecast
Rp1.23k
2026 Fair Value Forecast
Rp1.39k
2027 Fair Value Forecast
Rp1.65k
2028 Fair Value Forecast
Rp1.96k
2029 Fair Value Forecast
Rp1.68k
2030 Fair Value Forecast
Rp1.59k
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$765.00 Buy/Sell $636.99 3.27%
NOVO B Stock Forecast Novo Nordisk A/S Outperform 12
kr833.90 Buy/Sell kr696.07 -3.47%
JNJ Stock Forecast Johnson & Johnson Outperform 9
$160.98 Buy/Sell $174.55 5.60%
PG Stock Forecast Procter & Gamble Outperform 12
$159.30 Buy/Sell $166.80 6.72%
ABBV Stock Forecast AbbVie Outperform 9
$178.99 Buy/Sell $178.42 0.56%

Sun Pharmaceutical Industries Revenue Forecast for 2023 - 2025 - 2030

Sun Pharmaceutical Industries's Revenue has seen growth In the last three years, going from Rp328.38B to Rp438.86B – a gain of 33.65% In the next year, analysts believe that Revenue will reach Rp485.07B – an increase of 10.53%. For the next seven years, the forecast is forRevenue to grow by 31.35%.

2024 Rev Forecast
Rp485.07B
2025 Rev Forecast
Rp535.34B
2026 Rev Forecast
Rp588.07B
2027 Rev Forecast
Rp638.65B
2028 Rev Forecast
Rp582.70B
2029 Rev Forecast
Rp568.54B
2030 Rev Forecast
Rp576.44B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
NOVN Stock Forecast Novartis Outperform 10
CHF90.65 Buy/Sell CHF105.00 21.42%
ABT Stock Forecast Abbott Laboratories Outperform 9
$119.40 Buy/Sell $118.92 5.53%
AZN Stock Forecast AstraZeneca PLC Outperform 17
£103.28 Buy/Sell £165.99 55.61%

Sun Pharmaceutical Industries Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Dividend per Share for Sun Pharmaceutical Industries has grown by 187.50%, going from Rp4.00 to Rp11.50. 26 analysts predict Sun Pharmaceutical Industries's Dividend per Share will decrease by 6.35% in the next year, reaching Rp10.77. Over the next seven years, experts anticipate that Dividend per Share growth for Sun Pharmaceutical Industries will be 10.89%.

2024 DPS Forecast
Rp10.77
2025 DPS Forecast
Rp12.18
2026 DPS Forecast
Rp13.75
2027 DPS Forecast
Rp13.01
2028 DPS Forecast
Rp12.26
2029 DPS Forecast
Rp12.27
2030 DPS Forecast
Rp12.75
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PFE Stock Forecast Pfizer Outperform 2
$26.89 Buy/Sell $32.87 15.28%
AMGN Stock Forecast Amgen Outperform 4
$278.49 Buy/Sell $303.65 13.11%
ULVR Stock Forecast Unilever PLC Hold 8
£39.16 Buy/Sell £50.61 24.00%

Sun Pharmaceutical Industries Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
Rp85.79B
2025 FCF Forecast
Rp100.67B
2026 FCF Forecast
Rp113.45B
2027 FCF Forecast
Rp131.17B
2028 FCF Forecast
Rp113.87B
2029 FCF Forecast
Rp110.24B
2030 FCF Forecast
Rp112.07B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SAN Stock Forecast Sanofi Outperform 16
88.83€ Buy/Sell 102.80€ 20.45%
GSK Stock Forecast GSK Outperform 12
£16.71 Buy/Sell £17.30 10.11%
RKT Stock Forecast Reckitt Benckiser Group Outperform 12
£58.38 Buy/Sell £66.68 6.20%

Sun Pharmaceutical Industries EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Sun Pharmaceutical Industries's EBITDA has increased by 69.32%, going from Rp68.81B to Rp116.50B. In the next year, analysts are expecting an increase in EBITDA, predicting it will reach Rp130.02B – an increase of 11.60%. The Sun Pharmaceutical Industries forecast is for EBITDA to reach Rp165.96B or grow by 42.45%.

2024 EBITDA Forecast
Rp130.02B
2025 EBITDA Forecast
Rp148.52B
2026 EBITDA Forecast
Rp165.72B
2027 EBITDA Forecast
Rp195.06B
2028 EBITDA Forecast
Rp170.43B
2029 EBITDA Forecast
Rp164.20B
2030 EBITDA Forecast
Rp165.96B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ALC Stock Forecast Alcon Outperform 8
CHF70.94 Buy/Sell CHF90.64 31.10%
BEI Stock Forecast Beiersdorf Outperform 17
139.10€ Buy/Sell 137.41€ 4.96%
BAYN Stock Forecast Bayer Hold 5
29.14€ Buy/Sell 45.15€ 44.13%

Sun Pharmaceutical Industries EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Sun Pharmaceutical Industries's EBIT has grown, increasing from Rp49.72B to Rp93.05B – an increase of 87.15%. For next year, the 29 analysts predict EBIT of Rp104.17B, which would mean an increase of 11.96%. Over the next seven years, the pros' prediction is EBITof Rp137.94B, which would mean a seven-year growth forecast of 48.25%.

2024 EBIT Forecast
Rp104.17B
2025 EBIT Forecast
Rp121.31B
2026 EBIT Forecast
Rp137.21B
2027 EBIT Forecast
Rp165.65B
2028 EBIT Forecast
Rp141.97B
2029 EBIT Forecast
Rp136.26B
2030 EBIT Forecast
Rp137.94B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
COLO B Stock Forecast Coloplast A/S Hold 18
kr917.60 Buy/Sell kr812.28 -4.64%
CLX Stock Forecast Clorox Co-The Hold 16
$151.89 Buy/Sell $154.18 5.34%
FRE Stock Forecast Fresenius SE & Co. KGaA Outperform 18
26.08€ Buy/Sell 38.63€ 34.20%

Sun Pharmaceutical Industries EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Sun Pharmaceutical Industries's EPS has decreased from Rp16.60 to Rp0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach Rp38.93 – an increase of 100.00%. For the next seven years, the forecast is forEPS to grow by 100.00%.

2024 EPS Forecast
Rp38.93
2025 EPS Forecast
Rp45.20
2026 EPS Forecast
Rp51.01
2027 EPS Forecast
Rp60.60
2028 EPS Forecast
Rp71.90
2029 EPS Forecast
Rp61.61
2030 EPS Forecast
Rp58.56
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
TEVA Stock Forecast Teva Pharmaceutical Industries Outperform 12
$13.30 Buy/Sell $11.59 20.30%
CIPLA Stock Forecast Cipla Outperform 18
Rp1.49k Buy/Sell Rp1.43k -0.84%
500124 Stock Forecast Dr. Reddy's Laboratories Hold 18
Rp6.45k Buy/Sell Rp5.67k -7.16%